Express Scripts Weakness Viewed as Buying Opportunity and 4 Stock Analyses to See Now

Express Scripts Inc. (NASDAQ:ESRX) weakness is viewed by Bank of America Merrill Lynch as a buying opportunity, and the company mentioned recent positive industry commentary by Catamaran and CVS Caremark. Shares have a Buy rating and a $69 price target.

Fossil, Inc. (NASDAQ:FOSL): According to Citigroup, the company’s Q3 revenue deceleration will be made up during Q4. The firm recommends owning shares ahead of 2013 drivers. Shares have a Buy rating and a $108 price target.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Vitamin Shoppe, Inc. (NYSE:VSI) reported better Q3 results than predicted influencing RW Baird to think that the company is continuing to gain market share. The firm believes that the company’s margins have the ability to expand, and it keeps its Outperform rating on the stock.

Consolidated Edison Inc.’s (NYSE:ED) long-term earnings growth outlook is viewed by Argus as positive. The firm thinks the company is in the position to gain meaningful long-term returns, and it keeps its Buy rating and a $66 target on the stock.

The Chubb Corporation (NYSE:CB): According to Argus, Chubb’s valuation is now near its book value, which historically represented an attractive valuation. The firm views the company’s balance sheet as solid, and it keeps its Buy rating.

Don’t Miss: Multivitamin Study Could Be Bad News for These Stocks.